Author： Wacheck Volker
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.11, Iss.9, 2010-09, pp. : 1189-1191
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Inhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs
Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. :
Access to resources
Recommend
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. :
The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. :
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. :